Calcipotriol: A Review of its Pharmacological Properties and Therapeutic Use in Psoriasis Vulgaris

Drugs

Volumn 43, Issue 3, 1992, Pages 415-429

  Murdoch, David ^a   Clissold, Stephen P ^a  

^a ADIS INTERNATIONAL LIMITED   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE VALERATE; CALCIPOTRIOL; DITHRANOL; PLACEBO;

CALCIUM ABSORPTION; CALCIUM MOBILIZATION; CELL DIFFERENTIATION; CELL GROWTH; DESQUAMATION; DRUG EFFICACY; DRUG STRUCTURE; DRUG TOLERANCE; ERYTHEMA; HUMAN; HYPERCALCEMIA; INFLAMMATION; INTRAPERITONEAL DRUG ADMINISTRATION; PHARMACOKINETICS; PHARMACOLOGY; PRIORITY JOURNAL; PSORIASIS VULGARIS; REVIEW; SKIN DISEASE; SKIN IRRITATION; TOPICAL DRUG ADMINISTRATION; ULTRAVIOLET IRRADIATION;

ANTHRALIN; BETAMETHASONE; CALCITRIOL; CALCIUM; CELL DIFFERENTIATION; CELL DIVISION; COMBINED MODALITY THERAPY; HUMAN; PSORIASIS; RANDOMIZED CONTROLLED TRIALS;

EID: 0026589941     PISSN: 00126667     EISSN: 11791950     Source Type: Journal    
DOI: 10.2165/00003495-199243030-00007     Document Type: Article

References (41)

1. Vitamin D therapy in psoriasis
2. 3 analogue (MC 903)
3. Epidermal cytokeratin and immunocyte responses during treatment of psoriasis with calcipotriol and betamethasone valerate
4. Effects of a novel vitamin D analogue MC903 on cell proliferation and differentiation in vitro and on calcium metabolism in vivo
5. MC 903 — A novel vitamin D analogue with potent effects on cell proliferation and cell differentiation
6. Structure-function analysis of vitamin D analogs: difference in binding to the vitamin D receptor and vitamin-D binding serum protein
7. Comparative study of Calcipotriol (MC 903) ointment and betamethasone 17-valerate ointment in patients with psoriasis vulgaris
8. 3 analogue MC903 and betamethasone
9. Calcipotriol and hypercalcaemia
10. 3 on human osteoblast-like cells in vitro
11. The regulatory actions of MC903, a novel vitamin D3 analogue on human osteoblast-like cells in culture
12. Effects of topical calcipotriol on calcium metabolism in psoriatic patients: comparison with oral calcitriol
13. 3, MC 903, and their analogues herald a new pharmacologic era for the treatment of psoriasis?
14. Changes in epidermal keratin levels during treatment of psoriasis with topical vitamin D3 analogue MC903
15. 3
16. Treatment of psoriasis by the topical application of the novel cholecalciferol analogue calcipotriol (MC 903)
17. Improvement of psoriasis by a topical vitamin D3 analogue (MC 903) in a double-blind study
18. Long-term efficacy and tolerability of topical calcipotriol in psoriasis. Results of an open study
19. Double-blind, right/left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgaris
20. 3 analogue stimulates terminal differentiation and inhibits proliferation of cultured human keratinocytes
21. Combination of topical calcipotriol (MC 903) and UVB radiation for psoriasis vulgaris
22. Vitamin D3 analogues in psoriasis. Letters to the Editor
23. Calcipotriol and betamethasone valerate for psoriasis
24. 3 on alkaline phosphatase activity, osteocalcin and DNA synthesis by human osteoblastic cells in culture
25. 3 receptors in normal and psoriatic skin
26. 3 and a novel vitamin D analogue MC 903 are potent inhibitors of human interleukin 1 in vitro
27. Expression of interleukin-6-like molecules and tumour necrosis factor after topical treatment of psoriasis with a new vitamin D analogue (MC903)
28. Topical calcipotriol and hypercalcaemia
29. In vitro metabolism of calcipotriol (MC 903), a vitamin D analogue
30. Efficacy of topical treatment in psoriasis with MC903, a new vitamin D analogue
31. 3 and calcipotriol (MC903) have similar effects on the induction of osteoclast-like cell formation in human bone marrow cultures
32. Affinity of MC 903 for 1,25-dihydroxyvitamin D receptor and its effects on the synthesis of osteocalcin in human osteosarcoma cells
33. 3 analogue MC903 and betamethasone
34. Local application of vitamin D3 derivative MC903 in psoriasis: influence on cellular infiltrate, Langerhans cells and keratinocyte (KC) markers
35. 3 analogue